Probing of l-Arginine as an Additive for the Temperature-Induced Aggregation of Veterinary Growth Hormones: Fluorescence Study

The influence of l-arginine on the temperature-induced aggregation of porcine and mink growth hormones was studied by fluorescence spectroscopy. It was found that l-arginine suppresses the heat-induced aggregation. Moreover, the analysis of l-arginine interaction with the native proteins by fluorescence spectroscopy and circular dichroism spectroscopy revealed no significant changes in their native structure. On the basis of the results, l-arginine could be considered as a potential additive for the prevention of storage and temperature-related denaturation and aggregation of veterinary growth hormones.

[1]  J. Davagnino,et al.  Effects of pH and arginine on the solubility and stability of a therapeutic protein (Fibroblast Growth Factor 20): relationship between solubility and stability. , 2009, Current pharmaceutical biotechnology.

[2]  C. Stefanadis,et al.  Mechanisms of Disease: L-arginine in coronary atherosclerosis—a clinical perspective , 2007, Nature Clinical Practice Cardiovascular Medicine.

[3]  T. Arakawa,et al.  Effect of additives on protein aggregation. , 2009, Current pharmaceutical biotechnology.

[4]  J. Goldstein,et al.  Effects of arginine on photostability and thermal stability of IgG1 monoclonal antibodies. , 2009, Current pharmaceutical biotechnology.

[5]  J. Fitter,et al.  How aggregation and conformational scrambling of unfolded states govern fluorescence emission spectra. , 2006, Biophysical journal.

[6]  V. Bumelis,et al.  Refolding of porcine growth hormone from inclusion bodies of Escherichia coli , 2005 .

[7]  Daan J.A. Crommelin,et al.  Physical Methods to Characterize Pharmaceutical Proteins , 1995, Pharmaceutical Biotechnology.

[8]  P. Tripathi,et al.  Therapeutic role of L-arginine on free radical scavenging system in ischemic heart diseases. , 2009, Indian journal of biochemistry & biophysics.

[9]  S. d'Auria,et al.  Mink Growth Hormone Structural–Functional Relationships: Effects of Renaturing and Storage Conditions , 2008, The protein journal.

[10]  Hanns-Christian Mahler,et al.  Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.

[11]  J. Klindt,et al.  Administration of porcine somatotropin by sustained-release implant: growth and endocrine responses in genetically lean and obese barrows and gilts. , 1992, Journal of animal science.

[12]  D. Ejima,et al.  Is arginine a protein-denaturant? , 2005, Protein expression and purification.

[13]  Wei Wang,et al.  Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.

[14]  M. Sillence Technologies for the control of fat and lean deposition in livestock. , 2004, Veterinary journal.

[15]  K. Chattopadhyay,et al.  Effect of arginine on protein aggregation studied by fluorescence correlation spectroscopy and other biophysical methods. , 2009, Biochemistry.

[16]  K. Radzevičius,et al.  Production of recombinant mink growth hormone in E. coli , 2007, Applied Microbiology and Biotechnology.

[17]  W. C. Johnson,et al.  Structural information on proteins from circular dichroism spectroscopy possibilities and limitations. , 1995, Pharmaceutical biotechnology.

[18]  Brian M. Murphy,et al.  Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.

[19]  P. Tripathi,et al.  Oral administration of L-arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase , 2009, Oxidative medicine and cellular longevity.

[20]  R. Rudolph,et al.  Suppression of protein aggregation by L-arginine. , 2009, Current pharmaceutical biotechnology.

[21]  Christian Lange,et al.  l‐Arginine increases the solubility of unfolded species of hen egg white lysozyme , 2005, Protein science : a publication of the Protein Society.

[22]  V. Bumelis,et al.  l-Arginine Suppresses Aggregation of Recombinant Growth Hormones in Refolding Process from E. coli Inclusion Bodies , 2007, The protein journal.

[23]  J. Klindt,et al.  Administration of porcine somatotropin by sustained-release implant: growth factor and metabolic responses in crossbred white and genetically lean and obese boars and gilts. , 1995, Journal of animal science.

[24]  K. Kugiyama,et al.  Endothelial dysfunction in hypercholesterolemia is improved by L-arginine administration: possible role of oxidative stress. , 2002, Atherosclerosis.

[25]  M. Leone,et al.  Thermal aggregation of glycated bovine serum albumin. , 2010, Biochimica et biophysica acta.

[26]  D. Ejima,et al.  Biotechnology applications of amino acids in protein purification and formulations , 2007, Amino Acids.

[27]  C. L. Bashford,et al.  Spectrophotometry and spectrofluorimetry : a practical approach , 1987 .

[28]  Hyun-Jung Kim,et al.  Stabilization of Glycoprotein Liquid Formulation Using Arginine: A Study with Lactoferrin as a Model Protein , 2009, Bioscience, biotechnology, and biochemistry.

[29]  S. Fujiwara,et al.  Biophysical effect of amino acids on the prevention of protein aggregation. , 2002, Journal of biochemistry.

[30]  K. Tsumoto,et al.  The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. , 2003, Biochemical and biophysical research communications.